Larta Institute's Life Science Practice

Larta Institute’s ongoing and extensive connection within the early-stage life science community is rooted in programs & services that address the needs of key stakeholders (our customers) across the entire continuum of discovery, nurture, and development of new products, technologies, and services that address unmet human health challenges worldwide.

Innovators

The National Institutes of Health Commercialization Assistance Program is a nationwide ten-month program funded by NIH and managed and executed by Larta Institute. The program is designed to assist a select group of the most promising life science companies bring their technologies to market. The program comprises of training workshops, individual mentoring and consulting sessions, and public events in which companies present their technologies to the investment community, potential strategic partners and licensees.

Other commercialization programs clients include the National Institute of Standards and Technology, the Defense Advanced Research Projects Agency and the Department of Agriculture , which fund cutting-edge innovation in the life science and related sectors. In addition, Larta Institute also manages Network T2, a consortium of university technology transfer executives focused on facilitating licensing and partnership alliances with industry. 

Industry & Investment Partners

Larta Institute enjoys deep relationships with high level licensing, business development, and scientific executives within the life science community, who look to Larta to source, access, and meaningfully engage with companies at the cusp of cutting edge innovation. Our partners include Genentech, Genzyme, Johnson & Johnson, GlaxoSmithKline, Novartis, Pfizer, Medtronic, Amgen, Merck, Biogen Idec, Procter & Gamble, Baxter, Allergan, Boston Scientific, Invitrogen, BD Biosciences.  Larta also maintains relationships with life science-focused capital providers across the U.S. to identify early-stage opportunities on a year-round basis. 

Global Life Science Innovation

Larta Institute's Global Bridg Programs assist research institutes and technology centers around the world in accelerating the commercial potential of their most promising life science spinouts.  Larta Institute's transactional relationships with clients provide access and insight into global life science efforts and opportunities where innovation is applied to commercial market opportunities. Global Bridge partnerships: Korea (Korea Research Institute of Bioscience and Biotechnology), New Zealand (Foundation for Research Science and Technology), Taiwan (Institute for Information Industry), Israel (U.S.-Israel Science & Technology Foundation), Canada (Western Diversification, Canada), and others.

For more information visit www.larta.org